clinical trial · NCT07196501
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive DisorderNBI-1065845Placebo
brief summary
The primary objective of this study is to evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in delaying relapse of depressive symptoms (maintenance of effect) in participants with MDD.
started
Aug 18, 2025
primary completion
Jul 1, 2028
completion
Jul 1, 2028
last updated
Mar 19, 2026
official title
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Maintenance of Effect of NBI-1065845 as an Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol